A: Medication for tremor | |||
---|---|---|---|
Number of patients N = 26 | Yes | No | Unknown |
Preoperative | 12 (46) | 11 (42) | 3 (12) |
Postoperative | 5 (19) | 16 (62) | 5 (19) |
At follow-up | 9 (35) | 12 (46) | 5 (19) |
B: Patient self-report | |||
All (N = 26) | |||
VIM-DBS effect on tremor postoperative | 8.5 (0.1-10) | ||
VIM-DBS effect on tremor at follow-up | 7.4 (0.1-10) | ||
Overall satisfaction with VIM-DBS | 10 (0–10) | ||
C: Most common adverse effects with VIM-DBS | |||
Variable | All | ||
Number of patients | 26 | ||
Dysarthria | 17 (65) | ||
Headache | 9 (35) | ||
Parestesia | 6 (23) | ||
Abnormal taste | 8 (31) | ||
Dizziness | 5 (19) | ||
Discomfort tongue | 4 (15) | ||
Reduced balance or coordination | 4 (15) | ||
Other | 8 (31) |